We are live on
!
Find out more
Revolution Medicines
RVMD
RVMD
323 hedge funds and large institutions have $8.96B invested in Revolution Medicines in 2025 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 118 increasing their positions, 92 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
174% more call options, than puts
Call options by funds: $128M | Put options by funds: $47M
45% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 44
33% more funds holding in top 10
Funds holding in top 10: 18 → 24 (+6)
28% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 92
28% more capital invested
Capital invested by funds: $7.02B → $8.96B (+$1.94B)
5% more funds holding
Funds holding: 307 → 323 (+16)
0.24% more ownership
Funds ownership: 102.4% → 102.63% (+0.24%)
Holders
323
Holders Change
+16
Holders Change %
+5.21%
% of All Funds
4.24%
Holding in Top 10
24
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+33.33%
% of All Funds
0.32%
New
64
Increased
118
Reduced
92
Closed
44
Calls
$128M
Puts
$47M
Net Calls
+$81.5M
Net Calls Change
+$73.7M
Top Buyers
| 1 |
GA
General Atlantic
New York
|
+$96.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$42.1M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$38.9M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$33.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$30M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$55.4M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$39.4M |
| 3 |
Millennium Management
New York
|
-$37.3M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$32.4M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$28.9M |